Brenner MK - Search Results

1

Use of gene marking in bone marrow transplantation.

Heslop HE, Rooney CM, Rill DR, Krance RA, Brenner MK. Heslop HE, et al. Among authors: brenner mk. Cancer Detect Prev. 1996;20(2):108-13. Cancer Detect Prev. 1996. PMID: 8706035

2

An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.

Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J Jr, Krance RA, Ihle JN, Brenner MK. Rill DR, et al. Among authors: brenner mk. Blood. 1992 May 15;79(10):2694-700. Blood. 1992. PMID: 1316784 Free article.

3

Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.

Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK. Rill DR, et al. Among authors: brenner mk. Hum Gene Ther. 1992 Apr;3(2):129-36. doi: 10.1089/hum.1992.3.2-129. Hum Gene Ther. 1992. PMID: 1391032

4

Immunotherapy of leukemia.

Brenner MK, Heslop HE. Brenner MK, et al. Leukemia. 1992;6 Suppl 1:76-9. Leukemia. 1992. PMID: 1548941 Review.

5

Graft-versus-host reactions and bone-marrow transplantation.

Brenner MK, Heslop HE. Brenner MK, et al. Curr Opin Immunol. 1991 Oct;3(5):752-7. doi: 10.1016/0952-7915(91)90108-d. Curr Opin Immunol. 1991. PMID: 1836732

6

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.

Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE. Koehler M, et al. Among authors: brenner mk. Bone Marrow Transplant. 1994 May;13(5):571-5. Bone Marrow Transplant. 1994. PMID: 7519937

7

Gene transfer and bone marrow transplantation.

Brenner MK, Heslop HE, Rill D, Li C, Nilson T, Roberts M, Smith C, Krance R, Rooney C. Brenner MK, et al. Cold Spring Harb Symp Quant Biol. 1994;59:691-7. doi: 10.1101/sqb.1994.059.01.080. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587132 No abstract available.

8

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: brenner mk. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

9

Gene marking after bone marrow transplantation.

Brenner MK, Rill DR, Heslop HE, Rooney CM, Roberts WM, Li C, Nilson T, Krance RA. Brenner MK, et al. Eur J Cancer. 1994;30A(8):1171-6. doi: 10.1016/0959-8049(94)90478-2. Eur J Cancer. 1994. PMID: 7654451 Review. No abstract available.

10

Gene marking to improve the outcome of autologous bone marrow transplantation.

Brenner MK, Rill DR. Brenner MK, et al. Prog Clin Biol Res. 1994;389:587-91. Prog Clin Biol Res. 1994. PMID: 7700924 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters